12,372 trials
Periodic Fevers Syndrome
Primary: Number of Participants With Non-serious Adverse Events, Serious Adverse Events and Deaths — 1; 1; 0; 0 Participants
Lymphocytic Leukemia, Chronic
Primary: Percentage of Participants With Disease Progression (PD), Relapse, or Death Due to Any Cause Assessed According to the National Cancer Institute (NCI) Revised Guidelines…
Acne Vulgaris
Primary: Change in Inflammatory Lesion Counts — -58.44; -60.07; -53.28 percent change — p=0.0185
Herpes Zoster · Herpes Zoster Vaccine
Primary: Adjusted Geometric Means for Anti-glycoprotein E (gE) Antibodies in PreChemo Groups — 24501.57; 1056.77 EL.U/mL
Measles · Mumps · Rubella
Primary: Percentage of Subjects With Anti-measles Virus Antibody Concentration Equal to or Above the Cut-off-value (by Enzyme-linked Immunosorbent Assay [ELISA]) — 90.9; 94.3…
Type 2 Diabetes Mellitus
Primary: Number of Participants With Adverse Events — 11; 107 participants
Type 2 Diabetes Mellitus
Primary: Change From Baseline in Percentage of Glycated Hemoglobin (HbA1c) — -0.94; 0.00 percentage of HbA1c — p=<0.001
Type 2 Diabetes Mellitus
Primary: Change From Baseline in Percentage of Glycated Hemoglobin (HbA1c) — -0.97; -0.10 percentage of HbA1c — p=<0.001
Pain
Primary: Time-weighted Sum of Pain Relief and Pain Intensity Difference Scores From 0 to 12 Hours After the First Dose (SPRID 0-12) — 18.2; 41.5 units on a scale — p=<0.001
Seasonal Allergic Rhinitis
Primary: Change in Average AM and PM Subject-reported 12-hour Reflective Total Nasal Symptoms Score (rTNSS) From Baseline to End of Treatment. — 10.1; 10.3; 10.2; 10.2 units on a…
Hyperkalemia
Primary: Proportion of Subjects With Average Serum Potassium Values ≤ 5.1 mmol/L — 0.875; 0.822; 0.797; 0.862 Proportion of Participants
Hyperhidrosis
Primary: Percentage of Subjects Who Have a ≥4-point Improvement in the Weekly Mean Score of Axillary Sweating Daily Diary (ASDD) Item #2 From Baseline at Week 4 — 66.1; 26.9…
Hyperhidrosis
Primary: Percentage of Subjects Who Have a ≥4-point Improvement in the Weekly Mean Score of ASDD Item #2 From Baseline at Week 4 — 52.8; 28.3 percent of subjects — p=<0.001
Pediatrics · Muscle Spasticity · Cerebral Palsy
Primary: Average Change From Baseline in Modified Ashworth Scale-Bohannon (MAS-B) Score of the Principal Muscle Group at Weeks 4 and 6 — -1.87; -1.92; -1.21 score on a scale…
Fibromyalgia
Primary: Change From Baseline to 13 Week Endpoint in Brief Pain Inventory (BPI) Modified Short Form-adolescent Version 24 Hour Average Pain Severity Item — -1.62; -0.97 units on…